The Relationship Between Achalasia and Esophageal Cancer: The Experience of a Tertiary Center

Overview

Journal Eurasian J Med

Publisher Aves

Specialty General Medicine

Date 2022 Mar 21

PMID 35307628

Authors

Omer Ozturk

Mustafa Kaplan

Ilyas Tenlik

Volkan Gokbulut

Derya Ari

Yasemin Ozin

Affiliations

Soon will be listed here.

Abstract

Objective: We examined the prevalence of esophageal cancer in 828 patients diagnosed with achalasia and the characteristics of patients who developed esophageal cancer.

Material And Methods: The demographic characteristics and medical records of the patients who were followed up with a diagnosis of achalasia between 1995 and 2019 were investigated from the patient files.

Results: The mean age of the patients was 51 ± 17.3, 390 of them were males (47.1%) and 438 were females (52.9%). The mean diagnosis age of the patients was 45.4 years. The median follow-up duration of the patients was 73 months (12-480). Esophageal cancer developed in 5 patients (0.6%) during follow-up. Three of these 5 patients had squamous cell carcinoma (60%) and 2 had adenocarcinoma (40%). Three of these patients were males (60%) and 2 were females (40%). The mean age of the patients was 68 (56-78), and cancer developed after a median of 156 months (24-216) after the achalasia diagnosis. Balloon dilation therapy was performed for the treatment of achalasia in all 5 patients who developed esophageal cancer.

Conclusion: Achalasia patients have an increased risk of developing esophageal cancer compared to the general population, and patients should be followed closely for cancer development.

References

Markar S, Wiggins T, MacKenzie H, Faiz O, Zaninotto G, Hanna G . Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study. Dis Esophagus. 2019; 32(5). DOI: 10.1093/dote/doy106. View

Eckardt V, Gockel I, Bernhard G . Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004; 53(5):629-33. PMC: 1774039. DOI: 10.1136/gut.2003.029298. View

Boeckxstaens G, Annese V, Bruley des Varannes S, Chaussade S, Costantini M, Cuttitta A . Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011; 364(19):1807-16. DOI: 10.1056/NEJMoa1010502. View

Leeuwenburgh I, Scholten P, Alderliesten J, Tilanus H, Looman C, Steijerberg E . Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol. 2010; 105(10):2144-9. DOI: 10.1038/ajg.2010.263. View

Vela M, Richter J, Khandwala F, Blackstone E, Wachsberger D, Baker M . The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006; 4(5):580-7. DOI: 10.1016/s1542-3565(05)00986-9. View

Zaninotto G, Rizzetto C, Zambon P, Guzzinati S, Finotti E, Costantini M . Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg. 2008; 95(12):1488-94. DOI: 10.1002/bjs.6413. View

Napier K, Scheerer M, Misra S . Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 2014; 6(5):112-20. PMC: 4021327. DOI: 10.4251/wjgo.v6.i5.112. View

Zendehdel K, Nyren O, Edberg A, Ye W . Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol. 2011; 106(1):57-61. DOI: 10.1038/ajg.2010.449. View

Evans J, Early D, Fukami N, Ben-Menachem T, Chandrasekhara V, Chathadi K . The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012; 76(6):1087-94. DOI: 10.1016/j.gie.2012.08.004. View

10.

Ramchandani M, Reddy D, Nabi Z, Chavan R, Bapaye A, Bhatia S . Management of achalasia cardia: Expert consensus statements. J Gastroenterol Hepatol. 2018; 33(8):1436-1444. DOI: 10.1111/jgh.14097. View

11.

Brucher B, Stein H, Bartels H, Feussner H, Siewert J . Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg. 2001; 25(6):745-9. DOI: 10.1007/s00268-001-0026-3. View

12.

Guo J, Gilman P, Thomas R, Fisher R, Parkman H . Barrett's esophagus and achalasia. J Clin Gastroenterol. 2002; 34(4):439-43. DOI: 10.1097/00004836-200204000-00011. View

13.

Aslan F, Akpinar Z, Alper E, Atay A, Yurtlu D, Cekic C . The last innovation in achalasia treatment; per-oral endoscopic myotomy. Turk J Gastroenterol. 2015; 26(3):218-23. DOI: 10.5152/tjg.2015.0150. View

14.

Ribeiro Jr U, Posner M, Safatle-Ribeiro A, Reynolds J . Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996; 83(9):1174-85. View

15.

Ravi K, Geno D, Katzka D . Esophageal cancer screening in achalasia: is there a consensus?. Dis Esophagus. 2014; 28(3):299-304. DOI: 10.1111/dote.12196. View

16.

Costantini M, Salvador R, Capovilla G, Vallese L, Costantini A, Nicoletti L . A Thousand and One Laparoscopic Heller Myotomies for Esophageal Achalasia: a 25-Year Experience at a Single Tertiary Center. J Gastrointest Surg. 2018; 23(1):23-35. DOI: 10.1007/s11605-018-3956-x. View

17.

Moonen A, Annese V, Belmans A, Bredenoord A, Bruley des Varannes S, Costantini M . Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2015; 65(5):732-9. DOI: 10.1136/gutjnl-2015-310602. View

18.

Shah S, Butt A, Malik K, Alam A, Khan A . Pneumatic Balloon Dilatation for Achalasia Cardia; Early & late results, a single center study. Pak J Med Sci. 2017; 33(5):1053-1058. PMC: 5673706. DOI: 10.12669/pjms.335.13685. View

19.

Fabian E, Eherer A, Lackner C, Urban C, Smolle-Juettner F, Krejs G . Pseudoachalasia as First Manifestation of a Malignancy. Dig Dis. 2019; 37(5):347-354. DOI: 10.1159/000495758. View

20.

Aggestrup S, Holm J, SORENSEN H . Does achalasia predispose to cancer of the esophagus?. Chest. 1992; 102(4):1013-6. DOI: 10.1378/chest.102.4.1013. View